Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novavax Inc
NVAXCurrent price
7.32 USD
+0.18 USD (+2.52%)
Last closed
7.22 USD
Company
www.novavax.com
ISIN
US6700024010
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 426 437 504 USD
Yield for 12 month
+25.56 %
1Y
3Y
5Y
10Y
15Y
NVAX
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Address: 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.6 USDP/E ratio
–Dividend Yield
–Current Year
+983 705 000 USD
Last Year
+1 598 951 000 USD
Current Quarter
+415 484 000 USD
Last Quarter
+93 855 000 USD
Current Year
+704 237 000 USD
Last Year
+696 312 000 USD
Current Quarter
+379 442 000 USD
Last Quarter
+45 046 000 USD
Key Figures NVAX
1 year
3 years
5 years
10 years
EBITDA
-240 839 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.21 %
PEG Ratio
–
Return On Equity TTM
-898.2 %
Wall Street Target Price
19.6 USD
Revenue TTM
987 667 008 USD
Book Value
-2.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-2.1 %
Dividend Yield
–
Gross Profit TTM
-156 045 000 USD
Earnings per share
-2.62 USD
Diluted Eps TTM
-2.62 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
70.9 %
Profit Margin
-29.8 %
Dividend Analytics NVAX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NVAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
10.05.2019
Dividend Date
10.05.2019
Stock Valuation NVAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
1.7816
Enterprise Value Revenue
1.0888
Price Sales TTM
1.4442
Enterprise Value EBITDA
-0.534
Price Book MRQ
49.522
Financials NVAX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVAX
For 52 weeks
3.53 USD
23.86 USD
50 Day MA
11.68 USD
Shares Short Prior Month
33 879 071
200 Day MA
9.93 USD
Short Ratio
5.59
Shares Short
35 718 187
Short Percent
27.83 %
BeatStart